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Objective. To assess the vaginal inﬂammatory status (VIS) in pregnant women, whether symptomatic or asymptomatic, by
leukocyte quantiﬁcation in relation to the microbiota during each pregnancy trimester (T). Materials and Methods.At h o u s a n d
two hundred and forty eight vaginal exudates from pregnant women were prospectively examined. All the patients underwent a
clinicalandcolposcopicexaminationandamicrobiologicalstudyofvaginalexudates.Leukocytequantiﬁcationwasdeterminedby
May-Grunwald Giemsa staining as LNR per ﬁeld (400X). Results. Statistically signiﬁcant diﬀerences (SSD) in LNR were observed
in the VIS of asymptomatic patients (AP) compared with that of symptomatic ones (SP) with normal microbiota: 10–15 for the
1st T, <10, 20 to 25 and >25 for the 2nd T and >25 for the 3rd; with candidiasis: <10 for the 1st T, <10, 15 to 20 and >25 for the 2nd
Ta n d<10 and >25 for the 3rd T. In women with trichomoniasis, SSD in the LNR were observed between SP with LNR ≥ 10 and
AP with NLR < 10 in the three trimesters altogether. In women with BV, no SSD were observed in the LNR of any AP with respect
to SP for the three T. Conclusion. The VIS is inﬂuenced by vaginal microbiota and depends on the state of pregnancy and also, on
gestational age. The pronounced leukocyte increase in asymptomatic patients in the absence of lower genital tract infection during
the third trimester of pregnancy should be highlighted.
1.Introduction
Several hormonal changes are produced during pregnancy
that can increasingly predispose to infections of the lower
genital tract [1–4].
These infections are associated with a great number of
gynecologic and obstetric complications, such as preterm
birth [5–13], premature rupture of the membranes [14–
16],chorioamnionitis[17,18],postpartumendometritis[8],
inﬂammatory pelvic disease [19, 20], intrauterine growth
retardation [21], and low birth weight [13].
These maternal and perinatological complications could
be partly triggered by the local immune response as part
of the pathogenic mechanism generated by the infection
[22].
However, it is essential to ascertain whether this immu-
nological response of the vaginal mucosa is actually inﬂu-
enced by gestation. There is no literature available referring
to the vaginal inﬂammatory status (VIS) during pregnancy
expressed as leukocyte numerical range (LNR) by micro-
scopic observation.
The aim of this work was to assess VIS in pregnant
women, whether symptomatic or asymptomatic, by leuko-
cyte quantiﬁcation in relation to the normal microbiota and
the presence of candidiasis, trichomoniasis, and bacterial
vaginosis (BV) during each trimester of pregnancy (T).2 ISRN Obstetrics and Gynecology
Table 1:Distributionpertrimesterofleukocytenumericalrangesinpregnantpatients,whethersymptomaticorasymptomatic,withnormal
microbiota.
1st trimester l/f1 2nd trimester l/f1 3rd trimester l/f1
<10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25
Asymptomatic 91 11 6 4 7 157 15 11 6 9 307 45 11 19 29
S y m p t o m a t i c 7402081123 1 1 2105
AR2 1.77 −2.32 0.83 −1.98 0.90 2.32 0.13 −0.18 −2.02 −2.50 1.63 0.06 −0.67 0.96 −3.04
−1.77 2.32 −0.83 1.98 −0.90 −2.32 −0.13 0.18 2.02 2.50 −1.63 −0.06 0.67 −0.96 3.04
1Leukocytes/ﬁeld.
2Adjusted residuals.
Table 2: Distribution per trimester of leukocyte numerical ranges in pregnant patients, whether symptomatic or asymptomatic, with
candidiasis.
1st Trimester l/f1 2nd Trimester l/f1 3rd Trimester l/f1
<10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25
A s y m p t o m a t i c 2 5 3001 2 7 7112 5 2 8227
Symptomatic 8 2 2 2 2 17 2 9 4 9 26 8 7 5 14
AR2 2.63 −0.22 −1.95 −1.95 −1.17 2.65 1.89 −2.58 −1.30 −2.14 3.47 −0.36 −2.00 −1.40 −2.09
−2.63 0.22 1.95 1.95 1.17 −2.65 −1.89 2.58 1.30 2.14 −3.47 0.36 2.00 1.40 2.09
1Leukocytes/ﬁeld.
2Adjusted residuals.
Table 3:Distributioninthethreetrimestersofleukocytenumerical
ranges in pregnant patients, whether symptomatic or asymp-
tomatic, with trichomoniasis.
L/f
<10 10–>15
Asymptomatic 12 4
Symptomatic 7 15
L/f: Leukocytes per ﬁeld.
2.MaterialsandMethods
A thousand two hundred and forty-eight vaginal exudates
from pregnant women (231, 359, and, 658 in the ﬁrst,
second and third T, resp.) who were consecutively and
prospectively examined at the Obstetrics Clinic at Hospital
de Cl´ ınicas of the University of Buenos Aires, Argentina,
from July 1, 2005 to December 31, 2008, were analyzed.
This study was approved by the Hospital Ethics Commit-
tee. All the patients underwent a clinical and colposcopic
examinationandamicrobiologicalstudyofvaginalexudates.
Symptomatic patients showed pruritus and/or an increase
in vaginal discharge, which was thick, sticky, purulent,
smelly, thin and/or homogeneous depending on the case.
The microbiological study of vaginal exudates included the
following examinations:
(i) smears for Gram and prolonged May-Grunwald Gie-
msa staining,
(ii) microscopic wet smear examination with 1mL of
physiologic saline solution,
(iii) microscopic wet smear examination with sodium-
acetate acetic-acid formalin (SAF)/methylene blue
(0.5mL methylene blue and 0.5mL SAF) [23],
(iv) pH determination of vaginal exudates,
(v) ﬁshy-odor test with 1mL of 10% KOH with posterior
microscopic wet smear examination,
(vi) liquid medium culture (modiﬁed tioglycolate medi-
um) for Trichomonas vaginalis detection with seven-
day incubation period at 37◦Ci na na t m o s p h e r eo f
5% CO2 [24], and
(vii) solid medium culture (Modiﬁed Columbia Agar) in
5% human blood plates with 48 hour incubation
period at 37◦Ci na na t m o s p h e r eo f5 %C O 2.T h e
sample was preserved in Stuart transport medium.
The presence of Gram-positive bacilli in the Gram
staining and the development of small, point-like, and ´ α-
hemolytic colonies in the solid medium culture (Modiﬁed
Columbia Agar) in 5% human blood plates, was considered
normal or lactobacillary microbiota.
Candidiasis detection was performed by microscopic
wet smear examination with 1mL of 10% KOH and by
Sabouraud and blood agar culture.
The diagnosis of bacterial vaginosis (BV) was performed
bymeansof the Nugent’smethod throughthe determinationISRN Obstetrics and Gynecology 3
Table 4: Distribution per trimester of leukocyte numerical ranges in pregnant patients, whether symptomatic or asymptomatic, with
bacterial vaginosis.
1st trimester l/f1 2nd trimester l/f1 3rd trimester l/f1
<10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25 <10 10–15 15–20 20–25 >25
A s y m p t o m a t i c 1 9 100 0 1 3 320 1 2 9 830 5
S y m p t o m a t i c 2 3 512 5 3 4 5 1 2 5 6 3 9 512 9
1Leukocytes/ﬁeld.
of a score ≥7 in the Gram stain [25], and by the Amsel’s
method,thatisthepresenceofthreeormoreofthefollowing
criteria [26]:
(i) “clue-cells” in the Gram stain,
(ii) pH ≥ 4.5,
(iii) positive ﬁshy-odor test, and
(iv) thin and homogeneous vaginal discharge.
T. vaginalis detection was performed by direct micro-
scopic examination with physiologic saline solution and
SAF/methylene blue, prolonged May-Grunwald Giemsa
staining, and modiﬁed thioglycolate medium, which was
examined daily by wet smears for the detection of motile
parasites.
Leukocyte quantiﬁcation (without clumping) was deter-
mined by May-Grunwald Giemsa staining and was expressed
as LNR per ﬁeld (400x), by observation of 10 nonadjacent
microscopic ﬁelds.
2.1. Exclusion Criteria. Patients showing cervicitis in the
colposcopic exam were not included in the study.
2.2. Statistical Analysis. Fisher’s and chi-square tests χ2 were
performed to assess the VIS in relation to microbiota,
applying the calculation of adjusted residual (AR) in those
cases with P ≤ .05 to identify the LNRs which yielded the
signiﬁcance levels obtained (Epi info 6.04). LNRs with AR of
≥± 2 were considered those yielding the signiﬁcance levels
obtained.
3. Results
Statistically signiﬁcant diﬀerences resulting from the LNR
were observed in the VIS of asymptomatic pregnant patients
with normal microbiota compared with that of symptomatic
ones: 10 to 15 for the ﬁrst trimester, <10, 20, to 25 and >25
for the second trimester, and >25 for the third trimester (χ2:
10.73, P: .03, AR: ±2.32; χ2: 11.11, P: .02, AR: ±2.32 ± 2.02
y ± 2.50; χ2: 10.53, P: .03, AR: ±3.04, resp.) (Table 1).
In those patients with candidiasis, statistically signiﬁcant
diﬀerences in the LNR were observed in the VIS of asymp-
tomatic patients compared with symptomatic ones: <10 for
the ﬁrst trimester, <10, 15 to 20, and >25 for the second
trimester, and <10 and >25 for the third trimester (χ2: 10.40,
P: .03, AR: ±2.63; χ2: 17.60, P: .00, AR: ±2.65 ± 2.58 y ±
2.14; χ2: 14.24, P: .00, AR: ±3.47 and ±2.09, resp.) (Table 2).
With regard to patients with trichomoniasis (n: 38),
statistically signiﬁcant diﬀerences in the LNR were observed
between symptomatic patients with LRN ≥ 10 and asymp-
tomatic patients with LNR <10 in the three pregnancy
trimesters altogether (P Fisher: .01) (Table 3).
In women with BV, no statistically signiﬁcant diﬀerences
were observed in LNR of asymptomatic patients with respect
to symptomatic ones in any of the three trimesters (χ2: 7.05,
P: .13; χ2: 3.86, P: .43; χ2: 5.17, P: .27, resp.) (Table 4).
4. Discussion
With advancing gestation, a gradual increase in LNR (ﬁrst
trimester: 10 to 15, second trimester: 20 to >25, and third
trimester: >25) was observed in pregnant women with
lactobacillary microbiota. Therefore, in the last pregnancy
trimester, the >25 LNR was statistically signiﬁcant in the
absence of lower genital tract infection, mainly in asymp-
tomatic patients. Other authors such as Yamada et al. [27]
also described an increase in the number of leukocytes and
interleukin 8 (IL-8) as gestation advanced.
Furthermore, Gilbert et al. [28] reported that a sig-
niﬁcant increase of proinﬂammatory cytokines (IL-6 and
IL-8) is produced in the third trimester. These cytokines
act as chemoattractants of polymorphonuclear leukocytes
stimulating the expression of prostaglandins in response to
deliverypreparation.Thus,theseinterleukinsmaybeconsid-
ered markers for subsequent normal or preterm labor [29].
In addition, Gilbert et al. [28] observed that a decrease in
the production of inﬂammatory cytokines may occur during
the second trimester of pregnancy as part of the normal
course of pregnancy. Therefore, an increase of those cytoki-
nes in this trimester would produce preterm labor probably
related to an intrauterine or lower genital tract infection.
Furthermore, Gilbert et al. [28] reported that even in the
case of intrauterine bacterial infection, the increase of inﬂa-
mmatory cytokines is more pronounced than that expected
in a normal pregnancy in response to labor preparation.
According to the results of this study, the patients
with symptomatic candidiasis developed colpitis and were
associated with LNR greater than 25 in the second and third
trimester with positive microscopic examinations, whereas
the colposcopy was normal in asymptomatic candidiasis,
showingLNRlowerthan10inthethreepregnancytrimesters
with generally negative microscopic examinations. Further-
more, the patients with symptomatic trichomoniasis devel-
oped colpitis and were associated with LNR greater than 10,4 ISRN Obstetrics and Gynecology
with positive microscopic examinations. On the other
hand, in patients with asymptomatic trichomoniasis, the
colposcopy was normal and was only detected by culture,
that is, with generally negative microscopic examinations
and showing LNR under 10, considering the three trimesters
altogether.
However, no statistically signiﬁcant diﬀerences were
observed in any of the LNR of either symptomatic or
asymptomatic patients with BV, since this infection usually
occurs in the absence of an inﬂammatory reaction.
These results agree with those described in the literature
referring to the association of proinﬂammatory interleukins
(IL-6 and IL-8) with vaginitis, whereas in BV, there is an
increase of IL-1β (though lower than in vaginitis) but not
of the interleukins mentioned above [29, 30]. In addition,
Nenadi´ c et al. observed a correlation between leukocyte
count and IL-8 concentration and proposed microscopic
observation of the number of leukocytes as a useful tool for
identifying of patients with vaginal inﬂammation [31].
It is worth noticing that this work is the ﬁrst report
in the literature referring to vaginal inﬂammatory status
during pregnancy expressed as leukocyte numerical range by
microscopic observation, a universally studied methodology
used for the diagnosis of infections of the lower genital tract
in primary health care.
5. Conclusion
The vaginal inﬂammatory status is inﬂuenced by vaginal
microbiota and does not only depend on the state of preg-
nancybutalsoongestationalage.Therefore,thepronounced
leukocyte increase in asymptomatic patients in the absence
of lower genital tract infection during the third trimester of
pregnancy should be highlighted.
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